FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to novel compounds of formula (I) or their pharmaceutically acceptable salts used for the treatment or prevention of diseases, mediated by vitamin D receptors, as well as to a pharmaceutical composition, containing the said compounds. 
. In formula (I) a carbon atom, which X is bound to, has an S or R configuration, X represents -CH2OC(O)R2, Y1 and Y2 each represents hydrogen, Y3 and Y4 together form a methylene group, Z1 represents fluorine, a hydroxyl group or hydroxymethyl, Z2 represents fluorine or a hydroxyl group, R2 represents C1-10alkyl, C1-10alkylamino, C1-10alkylcarbonyloxyC1-10alkyl or hydroxyC1-10alkyl.
EFFECT: obtaining pharmaceutically acceptable salts, used for the treatment or prevention of disorders, mediated by the vitamin D receptors.
5 cl, 4 dwg, 6 tbl, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ADAMANTYL DERIVATIVES USEFUL FOR TREATMENT OF JNK-MEDIATED DISORDER | 2012 |
|
RU2626890C2 |
| ACYLBENZENE DERIVATIVES | 2011 |
|
RU2585765C2 |
| CGRP RECEPTOR ANTAGONISTS | 2004 |
|
RU2308458C2 |
| COMPOUNDS TARGETING TAU PROTEIN AND RELATED USE THEREOF | 2017 |
|
RU2805523C2 |
| AZABICYCLIC AND DIAZEPINE DERIVATIVES FOR THE TREATMENT OF OPHTHALMIC DISORDERS | 2018 |
|
RU2795521C2 |
| SUBSTITUTED BENZIMIDAZOLE COMPOUNDS, METHODS OF SYNTHESIS AND PHARMACEUTICAL COMPOSITION SHOWING ANTIVIRAL EFFECT BASED ON THEREOF | 1993 |
|
RU2141952C1 |
| TRI- OR TETPA-SUBSTITUTED-3-AMINOPYRROLIDINE DERIVATIVES | 2006 |
|
RU2420524C2 |
| NEW DERIVATIVE OF 3-AZABICYCLO[3.1.0]HEXANE AND USE THEREOF FOR MEDICAL PURPOSES | 2014 |
|
RU2701861C1 |
| SPIRO-FUSED PIPERIDINE DERIVATIVES FOR APPLICATION AS INHIBITORS OF EXTERNAL MEDULLAR LAYER POTASSIUM CHANNEL | 2013 |
|
RU2642066C2 |
| SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE DERIVATIVES OF PYRIMIDINES, COMPOSITIONS THEREOF AND METHODS OF TREATING USE THEREOF | 2012 |
|
RU2697712C2 |
